World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 7

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3826)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

143

HTML

1612

Figures (1-3)

429

Tables (1-2)

461

Sum=2645

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

125

Download

901

Sum=1026

Jul 15, 2024 (publication date) through Apr 1, 2026

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Zhang P, Jiang Q, Ding B, Yan RN, Hu Y, Ma JH. Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes. World J Diabetes 2024; 15(7): 1489-1498 [PMID: 39099829 DOI: 10.4239/wjd.v15.i7.1489]
URL:	https://www.wjgnet.com/1948-9358/full/v15/i7/1489.htm

Number	Citing Articles
1	Yan Xia, Yun Hu, Jian-Hua Ma. Premixed insulin: Advantages, disadvantages, and future. World Journal of Diabetes 2025; 16(3): 102526 doi: 10.4239/wjd.v16.i3.102526 Abstract(594) \| Core Tip(665) \| Full Article(HTML)(3371) \| Full Article with Cover (PDF)-988K(153) \| Audio-1039K(56) \| Peer-Review Report-230K(88) \| Answering Reviewers-134K(99) \| Full Article (PDF)-741K(187) \| Full Article (XML)-94K(99) \| Times Cited (1) \| Total Visits (6969) \| Open
2	Yu-Lan Wu, Xin Wang, Wei-Wei Zhang, Dan Feng, Xie Luo. Severe Insulin Resistance: Diagnosis and Management. Current Diabetes Reviews 2026; 22(5) doi: 10.2174/0115733998390048250902113845
3	Jinjing Wan, Leiluo Geng, Yiwen Fu, Qianting Zhang, Gaopeng Guan, Xue Jiang, Aimin Xu, Ping Jin. Clinical, genetic, and proteomic characteristics of type 2 diabetes complicated with exogenous insulin antibody syndrome: a case-control study. Diabetes Research and Clinical Practice 2025; 225: 112262 doi: 10.1016/j.diabres.2025.112262
4	Jinying Xia, Dan Yao, Jianping Chu, Ruiliang Wang, Zhiyan Chen. Six-Year Follow-Up of Glucagon-like peptide-1 receptor agonist (GLP1-RA) Therapy in a Patient With Exogenous Insulin Antibody Syndrome: A Case Report. AACE Endocrinology and Diabetes 2025; doi: 10.1016/j.aed.2025.12.008
5	M. Ishihara, N. Hattori, N. Nishiyama, T. Adachi, N. Toyoda, T. Saito. How to manage patients with diabetes suffering from unstable blood glucose control due to insulin antibodies. Endocrine 2026; 91(1) doi: 10.1007/s12020-025-04544-w
6	Jessica Oh, Evelyn Capellan Vasquez, Santiago Alvarez-Arango, Manish Ramesh, Mariana C. Castells. Insulin Allergy: The Allergist’s Updated Approach to Evaluation and Management. The Journal of Allergy and Clinical Immunology: In Practice 2025; 13(5): 990 doi: 10.1016/j.jaip.2025.02.028